Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aethlon Medical

0.3504
+0.00110.31%
Post-market: 0.3498-0.0006-0.19%19:46 EDT
Volume:99.97K
Turnover:32.63K
Market Cap:5.07M
PE:-0.35
High:0.3545
Open:0.3388
Low:0.3100
Close:0.3493
Loading ...

Company Profile

Company Name:
Aethlon Medical
Exchange:
NASDAQ
Establishment Date:
1984
Employees:
14
Office Location:
11555 Sorrento Valley Road,Suite 203,San Diego,California,United States
Zip Code:
92121
Fax:
619 941 0361
Introduction:
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.

Directors

Name
Position
Edward G. Broenniman
Chairman and Director
James B. Frakes
Interim Chief Executive Officer, Chief Financial Officer and Director
Angela Rossetti
Director
Chetan S. Shah
Director
Nicolas Gikakis
Director

Shareholders

Name
Position
James B. Frakes
Interim Chief Executive Officer, Chief Financial Officer and Director
Guy F. Cipriani
Senior Vice President, Chief Operating Officer
Steven P. LaRosa
Chief Medical Officer